title: Impact of hypertension on coronary artery spasm as assessed with intracoronary acetylcholine provocation test.
abstract: Both hypertension and coronary artery spasm (CAS) are associated with endothelial dysfunction. Thus, a higher incidence of CAS is expected in hypertensive patients. We evaluated the impact of hypertension on CAS with intracoronary acetylcholine (ACh) provocation test. A total of 986 patients (685 hypertensive patients vs 301 normotensive patients) who underwent coronary angiography with ACh provocation test were enrolled. ACh was injected into the left coronary artery in incremental doses of 20, 50 and 100 microg min(-1). Significant CAS was defined as a transient >70% luminal narrowing with concurrent chest pain and/or ST-segment changes. Although the incidences of significant ACh-induced CAS were similar between hypertensive and normotensive patients (35.8 vs 39.2%, P=0.303), multivariate logistic analysis showed that hypertension was negatively associated with ACh-induced CAS (odds ratio: 0.70, 95% confidence interval: 0.51-0.94, P=0.020). The angiographic characteristics of ACh-induced CAS were similar between these two groups. Subgroup analysis regarding the impact of the status of blood pressure control on CAS showed that hypertensive patients with controlled blood pressure had a significantly higher incidence of CAS than those with uncontrolled blood pressure (45.2 vs 27.9%, P<0.001), and that uncontrolled blood pressure was negatively associated with ACh-induced CAS (odds ratio: 0.56, 95% confidence interval: 0.40-0.79, P=0.001). In conclusion, despite the expected endothelial dysfunction, hypertension and uncontrolled blood pressure are negatively associated with CAS, suggesting that the mechanisms and risk factors of CAS may be significantly different from those of coronary artery disease.
authors.affiliation: Department of Internal Medicine, Cardiovascular Center, Korea University Guro Hospital, Seoul, Korea.
authors.forename: K-Y
authors.initials: KY
authors.lastname: Chen
authors.forename: S-W
authors.initials: SW
authors.lastname: Rha
authors.forename: Y-J
authors.initials: YJ
authors.lastname: Li
authors.forename: K L
authors.initials: KL
authors.lastname: Poddar
authors.forename: Z
authors.initials: Z
authors.lastname: Jin
authors.forename: Y
authors.initials: Y
authors.lastname: Minami
authors.forename: S
authors.initials: S
authors.lastname: Saito
authors.forename: J H
authors.initials: JH
authors.lastname: Park
authors.forename: J O
authors.initials: JO
authors.lastname: Na
authors.forename: C U
authors.initials: CU
authors.lastname: Choi
authors.forename: H E
authors.initials: HE
authors.lastname: Lim
authors.forename: J W
authors.initials: JW
authors.lastname: Kim
authors.forename: E J
authors.initials: EJ
authors.lastname: Kim
authors.forename: C G
authors.initials: CG
authors.lastname: Park
authors.forename: H S
authors.initials: HS
authors.lastname: Seo
authors.forename: D J
authors.initials: DJ
authors.lastname: Oh
mesh_terms: D000109:Acetylcholine / Q000008:administration & dosage; D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D044466:Asian People; D001794:Blood Pressure / Q000187:drug effects; D016022:Case-Control Studies; D017023:Coronary Angiography; D003329:Coronary Vasospasm / Q000175:diagnosis* / Q000208:ethnology / Q000209:etiology / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000188:drug therapy / Q000208:ethnology / Q000503:physiopathology; D007269:Injections, Intra-Arterial; D007723:Korea; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors; D014661:Vasoconstriction; D014662:Vasoconstrictor Agents / Q000008:administration & dosage
chemical_list: D000959:Antihypertensive Agents; D014662:Vasoconstrictor Agents; D000109:Acetylcholine